Conseil
 
N-1
 
N-2 
CFO (Jan 3 2022 ->)
Move' . _tr('hint.contact.drag') . '
 
Tax & Transfer Pricing
Move' . _tr('hint.contact.drag') . '
IR & Communications
Move' . _tr('hint.contact.drag') . '
Advisor to CEO
Move' . _tr('hint.contact.drag') . '
 
Solta Medical
Move' . _tr('hint.contact.drag') . '
 
R&D & Medical
Move' . _tr('hint.contact.drag') . '
 
Quality
Move' . _tr('hint.contact.drag') . '
 
Legal
Move' . _tr('hint.contact.drag') . '
 
Co-Head Bausch & Lomb Int'
Move' . _tr('hint.contact.drag') . '
Russia & CIS
Move' . _tr('hint.contact.drag') . '
Co-Head Bausch & Lomb Int'
Move' . _tr('hint.contact.drag') . '
Communication
Move' . _tr('hint.contact.drag') . '
Diversified Products
Move' . _tr('hint.contact.drag') . '
 
Salix Pharmaceuticals
Move' . _tr('hint.contact.drag') . '
 
Manufacturing & Supply Chain
Move' . _tr('hint.contact.drag') . '
Medical Device Quality
Move' . _tr('hint.contact.drag') . '
HR
Move' . _tr('hint.contact.drag') . '
 
Market Access
Move' . _tr('hint.contact.drag') . '
 
 
Mes dirigeants
Partager